A look at the weighted underlying holdings of the JPMorgan Healthcare Leaders ETF (JDOC) shows an impressive 11.8% of holdings on a weighted basis have experienced insider buying within the past six months.
Vertex Pharmaceuticals, Inc. (Symbol: VRTX), which makes up 1.78% of the JPMorgan Healthcare Leaders ETF (JDOC), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $145,972 worth of VRTX, making it the #19 largest holding. The table below details the recent insider buying activity observed at VRTX:
VRTX — last trade: $426.27 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 08/06/2025 | Reshma Kewalramani | CEO & President | 10,000 | $389.58 | $3,895,768 |
| 08/06/2025 | Bruce I. Sachs | Director | 5,000 | $389.68 | $1,948,416 |
10 ETFs With Stocks That Insiders Are Buying »
Also see:
Institutional Holders of FMET
ZION Historical PE Ratio
EOG 13F Filers
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
